J Cancer 2018; 9(24):4611-4617. doi:10.7150/jca.26794 This issue Cite

Research Paper

Detection of CK19 mRNA Using One-step Nucleic Acid Amplification (OSNA) in Prostate Cancer: Preliminary Results

Alexander Winter1✉, Svenja Engels1, Philipp Goos1, Marie-Christin Süykers1, Rolf-Peter Henke2, Holger Gerullis1, Friedhelm Wawroschek1

1. University Hospital for Urology, Klinikum Oldenburg, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, Rahel-Straus-Straße 10, 26133 Oldenburg, Germany
2. Institute of Pathology Oldenburg, Taubenstraße 28, 26122 Oldenburg, Germany

Citation:
Winter A, Engels S, Goos P, Süykers MC, Henke RP, Gerullis H, Wawroschek F. Detection of CK19 mRNA Using One-step Nucleic Acid Amplification (OSNA) in Prostate Cancer: Preliminary Results. J Cancer 2018; 9(24):4611-4617. doi:10.7150/jca.26794. https://www.jcancer.org/v09p4611.htm
Other styles

File import instruction

Abstract

Background: Accurate histopathological evaluation of lymph nodes (LNs) is essential for reliable staging in prostate cancer. In routine practice, conventional techniques only examine parts of the LN. Molecular nodal staging methods are limited by their high costs and extensive time requirement. One-step nucleic acid amplification (OSNA) determines the metastatic status of the complete LN and allows for rapid intraoperative detection of LN metastases. OSNA has been proposed for diagnosis of LN metastases from breast cancer by quantifying the CK19 mRNA copy number. To provide basic data for OSNA development for prostate cancer, we conducted an investigation of CK19 and OSNA in prostate cancer specimens.

Methods: OSNA is based on a short homogenization step and subsequent automated amplification of CK19 mRNA directly from the sample lysate, with results available in 30-40 min. A total of 20 prostate cancer specimens from consecutive patients with intermediate or high-risk prostate cancer (Gleason-Score ≥7) were investigated by both OSNA and conventional histopathology (H&E staining, CK19 immunohistochemistry). OSNA was performed on frozen samples using a ready-to-use amplification kit in an automated real-time detection system. Samples were defined as 'negative' or 'positive' according to mRNA copy number: >5000 copies/µl (++), 250-5000 copies/µl (+), and <250 copies/µl (-).

Results: Histopathological analysis confirmed prostate cancer in all samples: Gleason score 7 (n=11), Gleason score 8 (n=2), and Gleason score 9 (n=6). Gleason score could not be given for one patient who previously underwent hormonal treatment. OSNA analysis detected CK19 expression in 100% of the specimens and high numbers of CK19 mRNA copies in all cases (9 samples ++; 11 samples +). Immunohistochemistry confirmed CK19 expression in 19 of 20 cases. In the immunohistochemistry CK19-negative patient, a Gleason score 9 prostate cancer was diagnosed.

Conclusions: This is the first study using OSNA to detect CK19 expression in prostate cancer. Initial data indicate that this rapid method for molecular LN staging reliably identifies CK19 mRNA in prostate cancer. These results suggest that the OSNA assay may be suitable to improve (intraoperative) LN staging in prostate cancer. For further verification, OSNA analysis of LN specimens from prostate cancer patients is required.

Keywords: prostate cancer, CK19, OSNA, molecular lymph node staging, IDEAL-D


Citation styles

APA
Winter, A., Engels, S., Goos, P., Süykers, M.C., Henke, R.P., Gerullis, H., Wawroschek, F. (2018). Detection of CK19 mRNA Using One-step Nucleic Acid Amplification (OSNA) in Prostate Cancer: Preliminary Results. Journal of Cancer, 9(24), 4611-4617. https://doi.org/10.7150/jca.26794.

ACS
Winter, A.; Engels, S.; Goos, P.; Süykers, M.C.; Henke, R.P.; Gerullis, H.; Wawroschek, F. Detection of CK19 mRNA Using One-step Nucleic Acid Amplification (OSNA) in Prostate Cancer: Preliminary Results. J. Cancer 2018, 9 (24), 4611-4617. DOI: 10.7150/jca.26794.

NLM
Winter A, Engels S, Goos P, Süykers MC, Henke RP, Gerullis H, Wawroschek F. Detection of CK19 mRNA Using One-step Nucleic Acid Amplification (OSNA) in Prostate Cancer: Preliminary Results. J Cancer 2018; 9(24):4611-4617. doi:10.7150/jca.26794. https://www.jcancer.org/v09p4611.htm

CSE
Winter A, Engels S, Goos P, Süykers MC, Henke RP, Gerullis H, Wawroschek F. 2018. Detection of CK19 mRNA Using One-step Nucleic Acid Amplification (OSNA) in Prostate Cancer: Preliminary Results. J Cancer. 9(24):4611-4617.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image